Cargando…
Comparative metabolomic analysis of HPAC cells following the acquisition of erlotinib resistance
Pancreatic cancer is one of the most lethal types of cancer, due to difficulty in early detection and the limited efficacy of available treatments. Erlotinib is used to inhibit the epidermal growth factor receptor for the treatment of pancreatic cancer; however, erlotinib resistance is a major issue...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5431587/ https://www.ncbi.nlm.nih.gov/pubmed/28529573 http://dx.doi.org/10.3892/ol.2017.5940 |